期刊文献+

人股动脉粥样硬化相关蛋白的鉴定及其生物学作用 被引量:4

Proteomics analysis on pathogenesis of human atherosclerosis obliterans in human femoral artery
原文传递
导出
摘要 目的应用比较蛋白质组学方法探讨人动脉粥样硬化闭塞症(ASO)差异蛋白质的表达及其在ASO发病机制中的作用。方法选取ASO股动脉8例及正常股动脉5例,提取组织蛋白质,行双向凝胶电泳分离、质谱分析及数据库查询,获得差异蛋白信息。结果成功建立ASO和正常股动脉双向电泳图谱,含量相差大于2倍以上的蛋白质53个,27个上调,26个下调,质谱鉴定出13种蛋白质,主要与炎症、免疫、氧化应激、脂质代谢等相关。结论ASO与正常股动脉蛋白质组明显差异,差异蛋白质可能在ASO中起重要作用。 Objective We used proteomie profiling in an attempt to differentiate and identify histological proteins that were associated with atheroselerosis obliterans (ASO) of human femoral artery. Methods We comparatively analyzed the proteome of 8 atherosclerotic and 5 normal femoral arteries. The differentially expressed proteins were visualized by two dimensional electrophoresis (2-DE) and sequenced by matrix assisted laser desorption/ionization mass spectrometry (MALDI-TOF-MS). The protein identifi- cation program was used to search the National Center for Bioteehnology Information (NCBI) database and International Protein Index (IPI). Results A total of 53 distinct spots corresponding to 13 different proteins were identified by MALDI-TOF-MS using the NCBI and IPI databases. The function information of these 13 proteins mainly involved the pathogenetic mechanisms such as inflammation, innate immunity, oxidative stress, lipid metabolism, amyloid degeneration and so on. Conclusion ASO is associated with dis- tinct patterns of protein expression in the femoral arteries, and differentially expressed 13 proteins may con- tribute to the pathogenesis. These findings might provide needed biomarkers for ASO and new insight into its pathophysiology.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第4期490-492,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:上海市科委资助项目(08Jcl414100)
关键词 动脉粥样硬化闭塞症 股动脉 蛋白质组 质谱分析 Atherosclerosis obliterans Femoral artery Proteome Mass spectrometry
  • 相关文献

参考文献9

  • 1赵海光,付士军,蒋米尔.人腹主动脉瘤与动脉粥样硬化闭塞症基因表达谱差异的研究[J].中华实验外科杂志,2007,24(2):137-139. 被引量:9
  • 2Duperray A, Languino LR, Plescia J, et al. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem, 1997,272:435-441.
  • 3Naito M, Stirk CM, Smith EB, et al. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis. Thromb Res, 2000,98: 165-174.
  • 4Li XA, Hatanaka K, Ishibashi-Ueda H, et al. Characterization of serum amyloid P component from human aortic atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 1995,15 : 252-257.
  • 5Li XA, Yutani C, Shimokado K. Serum amyloid P component associ- ates with high density lipoprotein as well as very low density lipoprutein but not with low density lipoprotein. Biochem Biophys Res Commun, 1998,244:249-252.
  • 6Jenny NS, Amold AM, Kuller LH, et al. Serum amyloid P and cardio- vascular disease in older men and women:results from the Cardiovas- cular Health Study. Arterioscler Thromb Vasc Biol, 2007,27 : 352- 358.
  • 7Stewart CR, Haw III A, Lopez R, et al. Serum amyloid P colocalizes with apolipoproteins in human atheroma :functional implications. J Lip- id Res,2007 ,48 :2162-2171.
  • 8王春喜,韩丽娜,梁发启,姚迪,李荣,彭正.动脉硬化闭塞症手术前后血浆内皮素-1、一氧化氮测定的临床意义[J].中华实验外科杂志,2003,20(11):1035-1036. 被引量:2
  • 9Sardo MA, Mandraffino G, Campo S, et al. Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. Clin Chim Acta,2009,406:89-93.

二级参考文献10

共引文献9

同被引文献22

  • 1赵海光,付士军,蒋米尔.人腹主动脉瘤与动脉粥样硬化闭塞症基因表达谱差异的研究[J].中华实验外科杂志,2007,24(2):137-139. 被引量:9
  • 2Park HK,Park EC,Bae SW,et al.Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome.Circulation,2006,114:886-893.
  • 3Martin-Ventura JL,Nicolas V,Houard X,et al.Biological significance of decreased HSP27 in human atherosclerosis.Arterioscler Thromb Vasc Biol,2006,26:1337-1 343.
  • 4Larsen JK,Yamboliev IA,Weber LA,et al.Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle.Am J Physiol,1997,273:L930-940.
  • 5Somara S,Bitar KN.Tropomyosin interacts with phosphorylated HSP27 in agonist-induced contraction of smooth muscle.Am J Physiol Cell Physiol,2004,286:C1290-1301.
  • 6Pockley AG.Heat shock proteins,inflammation,and cardiovascular disease.Circulation,2002,105:1012-1017.
  • 7Tedgui A, Mallat Z. Cytokines in atherosclerosis:pathogenic and regu- latory pathways ,2006,86:515-581.
  • 8Libby P,Ridker PM,Maseri A.Inflammation in atherosclerosis.Circulation,2002,105:1135-1143.
  • 9Festa A,D' Agostino R Jr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance syndrome:the Insulin Resistance Atherosclerosis Study (IRAS).Circulation,2000,102:42-47.
  • 10Francesco C,Cesaria P,Barbara P,et al.Over expression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability.Circulation,2001,104:921-927.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部